University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
NCT Number: NCT04205708
Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.
Looking for future studies?
Notify Me30 year and older
All sexes
Observational
Oklahoma City, Oklahoma, 73104, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tuberculosis (TB) test: A blood sample is collected for lab testing to determine if you have tuberculosis (QuantiFeron test). Alternatively, the test is done by injecting a small amount of fluid (called tuberculin) into the skin on the lower part of the arm. A person given the tuberculin skin test must return within 48 to 72 hours to have a trained health care worker look for a reaction on the arm.
Other names: Mantoux skin test, QuantiFeron test
Chest X ray: non-invasive medical test that helps physicians diagnose and treat medical conditions of the lungs and chest. The Chest X-ray will be done to check for abnormalities on the lungs. The test is non-invasive.
A pulmonary function test (PFT, spirometry) is a breathing test that measures how much air your lungs can hold as well as how hard and fast you can blow air out of your lungs. The test is not invasive and involves blowing into a machine.
Other names: Spirometry, Forced Spirometry
Time frame: Single point assessment at baseline survey
Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)
Time frame: Single point assessment at baseline survey
Percentage of participants who report any exposure to silica
Time frame: Single point assessment at clinic visit
Percentage of participants with confirmed diagnosis of silicosis
Time frame: Single point assessment at baseline survey
Analysis to determine if any demographic, work history, or other trait correlates with increased silica exposure
University of Oklahoma
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00005280
Asbestosis, Chronic Disease
View Trial DetailsNCT06090370
Lung Diseases, Lung Diseases, Interstitial
Baltimore, Maryland, United States
View Trial DetailsNCT02430259
Actinomycetales Infections, Bacterial Infections
Taizhou, Zhejiang, China
View Trial DetailsNCT02794701
Lung Diseases, Lung Diseases, Interstitial
Hong Kong SAR, China
View Trial Details